This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1982-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982-1998
Title: Albert Louis Willemsens: Innovator in Pharmaceutical Chemistry
Introduction
Albert Louis Willemsens is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of enantiomerically pure compounds. With a total of 4 patents to his name, Willemsens has established himself as a key figure in his industry.
Latest Patents
Willemsens' latest patents include a process for preparing enantiomerically pure 6-{4-chlorophenyl}(1H-1,2,4-triazol-1-yl)methyl-1-methyl-1H-benzotriazole. This innovative process involves the resolution of (±)-6-{(4-chlorophenyl)-hydrazinomethyl}-1-methyl-1H-benzotriazole and converting the appropriate enantiomerically pure hydrazine intermediate into the desired compound. His work in this area demonstrates his commitment to advancing pharmaceutical research.
Career Highlights
Willemsens has spent a significant portion of his career at Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work has contributed to the development of new medications and therapeutic solutions, showcasing his expertise and dedication to improving healthcare outcomes.
Collaborations
Throughout his career, Willemsens has collaborated with esteemed colleagues such as Guido J Van Der Veken and Walter Louis Verstappen. These partnerships have fostered innovation and have been instrumental in the successful development of various pharmaceutical products.
Conclusion
Albert Louis Willemsens is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His contributions, particularly in the area of enantiomerically pure compounds, highlight his importance as an innovator. His ongoing efforts continue to shape the future of pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
